Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Evdokimov, A.G., Pokross, M., Walter, R., Mekel, M., Cox, B., Li, C., Bechard, R., Genbauffe, F., Andrews, R., Diven, C., Howard, B., Rastogi, V., Gray, J., Maier, M., Peters, K.G.(2006) Acta Crystallogr D Biol Crystallogr 62: 1435-1445
- PubMed: 17139078 
- DOI: 10.1107/S0907444906037784
- Primary Citation of Related Structures:  
2HC2, 2HC1, 2I3R, 2I3U, 2I4H, 2I4G, 2I4E, 2I5X - PubMed Abstract: 
Protein tyrosine phosphatases (PTPs) play roles in many biological processes and are considered to be important targets for drug discovery. As inhibitor development has proven challenging, crystal structure-based design will be very helpful to advance in ...